This report contains market size and forecasts of Tissue Engineered Skin Substitutes in global, including the following market information:
Global Tissue Engineered Skin Substitutes Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Tissue Engineered Skin Substitutes Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Tissue Engineered Skin Substitutes companies in 2020 (%)
The global Tissue Engineered Skin Substitutes market was valued at 1617.3 million in 2020 and is projected to reach US$ 2314.8 million by 2027, at a CAGR of 9.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tissue Engineered Skin Substitutes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tissue Engineered Skin Substitutes Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tissue Engineered Skin Substitutes Market Segment Percentages, By Type, 2020 (%)
Acellular
Cellular Allogeneic
Cellular Autologous
Others
Global Tissue Engineered Skin Substitutes Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tissue Engineered Skin Substitutes Market Segment Percentages, By Application, 2020 (%)
Burn Injury
Diabetic
Vascular Ulcer
Others
Global Tissue Engineered Skin Substitutes Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tissue Engineered Skin Substitutes Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tissue Engineered Skin Substitutes revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Tissue Engineered Skin Substitutes revenues share in global market, 2020 (%)
Key companies Tissue Engineered Skin Substitutes sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Tissue Engineered Skin Substitutes sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amarantus BioScience Holdings
Acelity L.P., Inc.
BSN medical
Integra LifeSciences Corporation
Medtronic (Covidien)
Molnlycke Health Care
Smith & Nephew plc
Organogenesis, Inc
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Tissue Engineered Skin Substitutes Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tissue Engineered Skin Substitutes Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tissue Engineered Skin Substitutes Overall Market Size
2.1 Global Tissue Engineered Skin Substitutes Market Size: 2021 VS 2027
2.2 Global Tissue Engineered Skin Substitutes Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Tissue Engineered Skin Substitutes Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Tissue Engineered Skin Substitutes Players in Global Market
3.2 Top Global Tissue Engineered Skin Substitutes Companies Ranked by Revenue
3.3 Global Tissue Engineered Skin Substitutes Revenue by Companies
3.4 Global Tissue Engineered Skin Substitutes Sales by Companies
3.5 Global Tissue Engineered Skin Substitutes Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tissue Engineered Skin Substitutes Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Tissue Engineered Skin Substitutes Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tissue Engineered Skin Substitutes Players in Global Market
3.8.1 List of Global Tier 1 Tissue Engineered Skin Substitutes Companies
3.8.2 List of Global Tier 2 and Tier 3 Tissue Engineered Skin Substitutes Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tissue Engineered Skin Substitutes Market Size Markets, 2021 & 2027
4.1.2 Acellular
4.1.3 Cellular Allogeneic
4.1.4 Cellular Autologous
4.1.5 Others
4.2 By Type - Global Tissue Engineered Skin Substitutes Revenue & Forecasts
4.2.1 By Type - Global Tissue Engineered Skin Substitutes Revenue, 2016-2021
4.2.2 By Type - Global Tissue Engineered Skin Substitutes Revenue, 2022-2027
4.2.3 By Type - Global Tissue Engineered Skin Substitutes Revenue Market Share, 2016-2027
4.3 By Type - Global Tissue Engineered Skin Substitutes Sales & Forecasts
4.3.1 By Type - Global Tissue Engineered Skin Substitutes Sales, 2016-2021
4.3.2 By Type - Global Tissue Engineered Skin Substitutes Sales, 2022-2027
4.3.3 By Type - Global Tissue Engineered Skin Substitutes Sales Market Share, 2016-2027
4.4 By Type - Global Tissue Engineered Skin Substitutes Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tissue Engineered Skin Substitutes Market Size, 2021 & 2027
5.1.2 Burn Injury
5.1.3 Diabetic
5.1.4 Vascular Ulcer
5.1.5 Others
5.2 By Application - Global Tissue Engineered Skin Substitutes Revenue & Forecasts
5.2.1 By Application - Global Tissue Engineered Skin Substitutes Revenue, 2016-2021
5.2.2 By Application - Global Tissue Engineered Skin Substitutes Revenue, 2022-2027
5.2.3 By Application - Global Tissue Engineered Skin Substitutes Revenue Market Share, 2016-2027
5.3 By Application - Global Tissue Engineered Skin Substitutes Sales & Forecasts
5.3.1 By Application - Global Tissue Engineered Skin Substitutes Sales, 2016-2021
5.3.2 By Application - Global Tissue Engineered Skin Substitutes Sales, 2022-2027
5.3.3 By Application - Global Tissue Engineered Skin Substitutes Sales Market Share, 2016-2027
5.4 By Application - Global Tissue Engineered Skin Substitutes Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Tissue Engineered Skin Substitutes Market Size, 2021 & 2027
6.2 By Region - Global Tissue Engineered Skin Substitutes Revenue & Forecasts
6.2.1 By Region - Global Tissue Engineered Skin Substitutes Revenue, 2016-2021
6.2.2 By Region - Global Tissue Engineered Skin Substitutes Revenue, 2022-2027
6.2.3 By Region - Global Tissue Engineered Skin Substitutes Revenue Market Share, 2016-2027
6.3 By Region - Global Tissue Engineered Skin Substitutes Sales & Forecasts
6.3.1 By Region - Global Tissue Engineered Skin Substitutes Sales, 2016-2021
6.3.2 By Region - Global Tissue Engineered Skin Substitutes Sales, 2022-2027
6.3.3 By Region - Global Tissue Engineered Skin Substitutes Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Tissue Engineered Skin Substitutes Revenue, 2016-2027
6.4.2 By Country - North America Tissue Engineered Skin Substitutes Sales, 2016-2027
6.4.3 US Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.4.4 Canada Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.4.5 Mexico Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Tissue Engineered Skin Substitutes Revenue, 2016-2027
6.5.2 By Country - Europe Tissue Engineered Skin Substitutes Sales, 2016-2027
6.5.3 Germany Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.4 France Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.5 U.K. Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.6 Italy Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.7 Russia Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.8 Nordic Countries Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.5.9 Benelux Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Tissue Engineered Skin Substitutes Revenue, 2016-2027
6.6.2 By Region - Asia Tissue Engineered Skin Substitutes Sales, 2016-2027
6.6.3 China Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.6.4 Japan Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.6.5 South Korea Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.6.6 Southeast Asia Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.6.7 India Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Tissue Engineered Skin Substitutes Revenue, 2016-2027
6.7.2 By Country - South America Tissue Engineered Skin Substitutes Sales, 2016-2027
6.7.3 Brazil Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.7.4 Argentina Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tissue Engineered Skin Substitutes Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Tissue Engineered Skin Substitutes Sales, 2016-2027
6.8.3 Turkey Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.8.4 Israel Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.8.5 Saudi Arabia Tissue Engineered Skin Substitutes Market Size, 2016-2027
6.8.6 UAE Tissue Engineered Skin Substitutes Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Amarantus BioScience Holdings
7.1.1 Amarantus BioScience Holdings Corporate Summary
7.1.2 Amarantus BioScience Holdings Business Overview
7.1.3 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Major Product Offerings
7.1.4 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.1.5 Amarantus BioScience Holdings Key News
7.2 Acelity L.P., Inc.
7.2.1 Acelity L.P., Inc. Corporate Summary
7.2.2 Acelity L.P., Inc. Business Overview
7.2.3 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Major Product Offerings
7.2.4 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.2.5 Acelity L.P., Inc. Key News
7.3 BSN medical
7.3.1 BSN medical Corporate Summary
7.3.2 BSN medical Business Overview
7.3.3 BSN medical Tissue Engineered Skin Substitutes Major Product Offerings
7.3.4 BSN medical Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.3.5 BSN medical Key News
7.4 Integra LifeSciences Corporation
7.4.1 Integra LifeSciences Corporation Corporate Summary
7.4.2 Integra LifeSciences Corporation Business Overview
7.4.3 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Major Product Offerings
7.4.4 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.4.5 Integra LifeSciences Corporation Key News
7.5 Medtronic (Covidien)
7.5.1 Medtronic (Covidien) Corporate Summary
7.5.2 Medtronic (Covidien) Business Overview
7.5.3 Medtronic (Covidien) Tissue Engineered Skin Substitutes Major Product Offerings
7.5.4 Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.5.5 Medtronic (Covidien) Key News
7.6 Molnlycke Health Care
7.6.1 Molnlycke Health Care Corporate Summary
7.6.2 Molnlycke Health Care Business Overview
7.6.3 Molnlycke Health Care Tissue Engineered Skin Substitutes Major Product Offerings
7.6.4 Molnlycke Health Care Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.6.5 Molnlycke Health Care Key News
7.7 Smith & Nephew plc
7.7.1 Smith & Nephew plc Corporate Summary
7.7.2 Smith & Nephew plc Business Overview
7.7.3 Smith & Nephew plc Tissue Engineered Skin Substitutes Major Product Offerings
7.4.4 Smith & Nephew plc Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.7.5 Smith & Nephew plc Key News
7.8 Organogenesis, Inc
7.8.1 Organogenesis, Inc Corporate Summary
7.8.2 Organogenesis, Inc Business Overview
7.8.3 Organogenesis, Inc Tissue Engineered Skin Substitutes Major Product Offerings
7.8.4 Organogenesis, Inc Tissue Engineered Skin Substitutes Sales and Revenue in Global (2016-2021)
7.8.5 Organogenesis, Inc Key News
8 Global Tissue Engineered Skin Substitutes Production Capacity, Analysis
8.1 Global Tissue Engineered Skin Substitutes Production Capacity, 2016-2027
8.2 Tissue Engineered Skin Substitutes Production Capacity of Key Manufacturers in Global Market
8.3 Global Tissue Engineered Skin Substitutes Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tissue Engineered Skin Substitutes Supply Chain Analysis
10.1 Tissue Engineered Skin Substitutes Industry Value Chain
10.2 Tissue Engineered Skin Substitutes Upstream Market
10.3 Tissue Engineered Skin Substitutes Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tissue Engineered Skin Substitutes Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Tissue Engineered Skin Substitutes in Global Market
Table 2. Top Tissue Engineered Skin Substitutes Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Tissue Engineered Skin Substitutes Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Tissue Engineered Skin Substitutes Revenue Share by Companies, 2016-2021
Table 5. Global Tissue Engineered Skin Substitutes Sales by Companies, (K Units), 2016-2021
Table 6. Global Tissue Engineered Skin Substitutes Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Tissue Engineered Skin Substitutes Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Tissue Engineered Skin Substitutes Product Type
Table 9. List of Global Tier 1 Tissue Engineered Skin Substitutes Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tissue Engineered Skin Substitutes Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Amarantus BioScience Holdings
Acelity L.P., Inc.
BSN medical
Integra LifeSciences Corporation
Medtronic (Covidien)
Molnlycke Health Care
Smith & Nephew plc
Organogenesis, Inc